Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units
Arno Müller(Centre Hospitalier Universitaire de Besançon), Xavier Bertrand(Centre National de la Recherche Scientifique), Evelyne Belle(Centre Hospitalier Universitaire de Besançon), Gilles Cappelier(Centre Hospitalier Universitaire de Besançon), D. Talon(Centre National de la Recherche Scientifique), Alexandre Potier(Centre Hospitalier Universitaire de Besançon)
Cited by 58
Related Papers
Endemicity, molecular diversity and colonisation routes of Pseudomonas aeruginosa in intensive care units
|Intensive Care Medicine|2001|189
Wastewater Treatment Plants Release Large Amounts of Extended-Spectrum β-Lactamase–Producing Escherichia coli Into the Environment
|Clinical Infectious Diseases|2014|172
Pseudomonas aeruginosa: antibiotic susceptibility and genotypic characterization of strains isolated in the intensive care unit
|Clinical Microbiology and Infection|2001|169
The role of the hospital environment in the epidemiology of multi-resistant bacteria
|Journal of Hospital Infection|1999|130
Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study
|Journal of Hospital Infection|2014|128